190 related articles for article (PubMed ID: 36510632)
21. Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.
Wang YS; Cao R; Jin H; Huang YP; Zhang XY; Cong Q; He YF; Xu CJ
J Hematol Oncol; 2011 Apr; 4():15. PubMed ID: 21489304
[TBL] [Abstract][Full Text] [Related]
22. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
[TBL] [Abstract][Full Text] [Related]
23. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of serum lncRNA CATG00000112921.1 as a marker of multiple myeloma.
Gao J; Qu J; Xiao B; Huang Q; Zhu C; Dai Z; Wu K; Li L; Zeng T
Curr Probl Cancer; 2024 Feb; 48():101057. PubMed ID: 38070464
[TBL] [Abstract][Full Text] [Related]
25. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
27. New serum biomarker identification and analysis by mass spectrometry in cervical precancerous lesion and acute cervicitis in South China.
Qiu F; Su B; Li Z; Chen W; Cao L; Chen F; Liu D; He J; Lin N
Cancer Manag Res; 2019; 11():6151-6162. PubMed ID: 31308751
[No Abstract] [Full Text] [Related]
28. A functional Cis-eQTL locus in lncRNA ZNRD1-AS1 contributes to the susceptibility of endometrial cancer.
Peng JT; Li MC
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7802-7807. PubMed ID: 31599404
[TBL] [Abstract][Full Text] [Related]
29. Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endometrial carcinoma.
Zhai W; Li X; Wu S; Zhang Y; Pang H; Chen W
Int J Oncol; 2015 May; 46(5):2125-37. PubMed ID: 25695231
[TBL] [Abstract][Full Text] [Related]
30. LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview.
Shetty A; Venkatesh T; Kabbekodu SP; Tsutsumi R; Suresh PS
Arch Gynecol Obstet; 2022 Nov; 306(5):1431-1447. PubMed ID: 35182183
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Ling X; Fang C; Ma J
Cell Mol Biol Lett; 2022 May; 27(1):39. PubMed ID: 35578166
[TBL] [Abstract][Full Text] [Related]
32. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
[TBL] [Abstract][Full Text] [Related]
33. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker.
Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J
J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481
[TBL] [Abstract][Full Text] [Related]
34. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
Zhou M; Zhang Z; Zhao H; Bao S; Sun J
BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
[TBL] [Abstract][Full Text] [Related]
35. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma.
Zhou X; Zhang H; Duan Y; Zhu J; Dai H
J Clin Lab Anal; 2023 Jan; 37(1):e24813. PubMed ID: 36525280
[TBL] [Abstract][Full Text] [Related]
36. Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
Biomed Res Int; 2022; 2022():2056913. PubMed ID: 35937391
[TBL] [Abstract][Full Text] [Related]
37. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
38. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
39. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
Ouyang D; Li R; Li Y; Zhu X
J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
[TBL] [Abstract][Full Text] [Related]
40. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]